VRSK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Verisk Analytics Inc (VRSK) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock is currently trading below key moving averages, indicating a bearish trend. Insider selling has increased significantly, and there are no strong proprietary trading signals to suggest a short-term opportunity. While the company's financial performance shows modest growth and analysts maintain a long-term bullish outlook, the near-term setup appears weak. It is better to hold off on buying until there are clearer positive signals or a more favorable entry point.
The stock is in a bearish trend with the MACD histogram below 0 (-2.879) and negatively contracting. RSI is neutral at 32.151, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 168.413, and resistance is at 188.991. The stock has a 60% chance of declining in the next week and month based on similar candlestick patterns.
BMO Capital upgraded the stock to Outperform, citing an attractive entry point and potential catalysts from the upcoming investor day.
Modest financial growth in Q3 2025, with revenue up 5.93% YoY and EPS up 4.55% YoY.
Appointment of Steven Kauderer as president of Claims Solutions to enhance operational efficiency.
Insider selling has increased by 651.16% over the last month.
Analysts have lowered price targets recently, reflecting cautious near-term sentiment.
Technical indicators suggest a bearish trend, with the stock trading below key moving averages.
High implied volatility (IV percentile 98.
indicates uncertainty and potential downside risk.
In Q3 2025, Verisk Analytics reported revenue growth of 5.93% YoY to $768.3M, net income growth of 2.45% YoY to $225.5M, and EPS growth of 4.55% YoY to $1.61. Gross margin increased slightly to 59.42%, up 1.28% YoY. Overall, the financial performance shows modest growth trends.
Analysts are mixed but cautiously optimistic. Wells Fargo lowered the price target to $237 from $280, citing a cautious near-term setup but maintaining an Overweight rating. BMO Capital upgraded the stock to Outperform, citing an attractive entry point and potential catalysts. Morgan Stanley lowered the price target to $270 from $290, reflecting concerns over AI-driven bifurcation in the industry.
